Trial intelligence / Profile preview

Remimazolam versus propofol for general anesthesia in laparoscopic cholecystectomy

ChiCTR2000030440Phase 4Not yet recruiting

Sponsor
Yantai Yuhuangding Hospital
Start
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of remimazolam and propofol in cholelithiasis (2 arms), sponsored by Yantai Yuhuangding Hospital. Primary endpoints: Hemodynamic changes, Bispectral index and 5 more. Planned start Mar 2020; status: not yet recruiting.

02

Drugs

remimazolampropofol
03

Conditions

cholelithiasis

Beyond the preview

Go deeper on ChiCTR2000030440.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000030440.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call